Literature DB >> 21502994

Targeted therapies: bevacizumab and chemotherapy do not increase the risk of VTEs.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2011        PMID： 21502994     DOI： 10.1038/nrclinonc.2011.53

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies.

Authors:  Herbert I Hurwitz; Leonard B Saltz; Eric Van Cutsem; James Cassidy; Jonas Wiedemann; Florin Sirzén; Gary H Lyman; Ulrich-Peter Rohr
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.